KIKA provides Veracity advanced EDC platform for Clinical Asset Management

KIKA™ Clinical Solutions will welcome customers and partners who are driving the adoption of EDC for clinical trials at its second annual U.S. User Group Meeting in Boston, Mass., October 19 and 20. KIKA provides the Veracity™ advanced EDC platform for Clinical Asset Management™ to the pharmaceutical, biotechnology and medical device industries.

“The User Group Meeting gives participants a unique opportunity to share experiences and ideas about using Veracity™ and Clinical Asset Management™. KIKA will use feedback to continue offering customers the most innovative and reliable EDC solutions to collect, protect and maximize their most important clinical asset - their data.”

The information-packed agenda will offer presentations, breakout sessions and panels that address the clinical data management, regulatory, compliance, and economic aspects of clinical trials. Topics include:

• Practical Aspects of an EDC Implementation
• Planning, Tracking, and Integrating Clinical Finances in Your Trial
• Event Adjudication: A Case Study from the Site and CEC Perspective
• Training Needs and Requirements
• Customer Requirements Documents
• What's the Best Way to Perform User Acceptance Testing

Additionally, KIKA will demonstrate new features in Veracity™ 3.10 released last month, and will preview Veracity™ 3.11, scheduled for spring 2011.

KIKA CEO Linda Beneze said, "The User Group Meeting gives participants a unique opportunity to share experiences and ideas about using Veracity™ and Clinical Asset Management™. KIKA will use feedback to continue offering customers the most innovative and reliable EDC solutions to collect, protect and maximize their most important clinical asset - their data."